CIK 0000886163
- Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 770160744
- Phone
- +1 858-550-7500
- Business address
- 7111 FAIRWAY DRIVE, SUITE 302, PALM BEACH GARDENS, FL, 33418
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,384,247
- in 9 filings, $4.7M under 10b5-1 plans
Net −$7,384,247. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-02-10 | Berkman Charles S VP, Gen. Counsel & Secretary | Grant or award · Employee Stock Option (right to buy) | +16,057 | $56.26 | $903K | 16,057 |
| 2015-02-10 | HIGGINS JOHN L President & CEO | Grant or award | +15,945 | 136,044 | ||
| 2015-02-10 | HIGGINS JOHN L President & CEO | Grant or award · Employee Stock Option (right to buy) | +56,198 | $56.26 | $3.2M | 56,198 |
| 2014-12-31 | Berkman Charles S VP, Gen. Counsel & Secretary | Other acquisition | +126 | $45.23 | $6K | 27,433 |
| 2014-12-31 | Herman Melanie J Director of Accounting | Other acquisition | +103 | $45.23 | $5K | 2,831 |
| 2014-12-31 | Berkman Charles S VP, Gen. Counsel & Secretary | Purchase | +126 | $45.23 | $6K | 27,433 |
| 2014-12-31 | FOEHR MATTHEW W EVP and COO | Purchase | +46 | $45.23 | $2K | 55,016 |
| 2014-12-31 | Herman Melanie J Director of Accounting | Purchase | +103 | $45.23 | $5K | 2,831 |
| 2014-12-31 | Aryeh Jason Director | Gift | −3,283 | 57,412 | ||
| 2014-11-24 | LAMATTINA JOHN L Director | Gift | −2,785 | 20,055 | ||
| 2014-10-15 | KOZARICH JOHN W Director | Purchase | +2,000 | $45.68 | $91K | 49,286 |
| 2014-10-13 | FOEHR MATTHEW W EVP and COO | Exercise or conversion | +1,000 | $9.97 | $10K | 54,970 |
| 2014-10-13 | FOEHR MATTHEW W EVP and COO | Exercise or conversion · Employee Stock Option (right to buy) | −1,000 | 132,056 | ||
| 2014-10-10 | FOEHR MATTHEW W EVP and COO | Purchase | +85 | $44.91 | $4K | 53,970 |
| 2014-10-09 | Sabba Stephen L Director | Purchase | +2,000 | $43.12 | $86K | 23,697 |
| 2014-10-09 | KNOTT DAVID M Director | Purchase | +4,000 | $43.01 | $172K | 69,227 |
| 2014-10-09 | Sabba Stephen L Director | Grant or award | +2,000 | $43.12 | $86K | 23,697 |
| 2014-10-09 | KNOTT DAVID M Director | Grant or award | +4,000 | $43.01 | $172K | 69,227 |
| 2014-10-09 | Aryeh Jason Director | Purchase | +11,000 | $42.99 | $473K | 255,716 |
| 2014-10-07 | KOZARICH JOHN W Director | Exercise or conversion | +2,500 | $8.58 | $21K | 47,286 |
Page 71 of 86 · 1,712 trades